Stem Cell Agency Governing Board Meeting 8/18 & 8/19, 2010

Day 1
Aug 18, 2010
Main Location: 

Paul Brest Hall
Munger Complex
Stanford University
Stanford, CA 94305

Additional Locations: 
Hilton Garden Inn Boise/Eagle 145 E. Riverside Drive Eagle, Idaho, 83616
628 Pacific View Drive San Diego, CA 92109
City of Hope 1500 E. Duarte Road Duarte, California 91010
Salk Institute 10010 N. Torrey Pines Rd., La Jolla, CA 92037
Call-in Information: 
URL: http://205.144.147.162/cgi-bin/confCast Enter Conference ID# 167222 and click "Go"
Day 2
Aug 19, 2010
Main Location: 

Paul Brest Hall
Munger Complex
Stanford University
Stanford, CA 94305

Additional Locations: 
Hilton Garden Inn Boise/Eagle 145 E. Riverside Drive Eagle, Idaho, 83616
628 Pacific View Drive San Diego, CA 92109
City of Hope 1500 E. Duarte Road Duarte, California 91010
Salk Institute 10010 N. Torrey Pines Rd., La Jolla, CA 92037
Call-in Information: 
URL: http://205.144.147.162/cgi-bin/confCast Enter Conference ID# 167224 and click "Go

Stem Cell Agency Governing Board Meeting

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 

1. Call to Order.

2. Pledge of Allegiance.

3. Roll Call.

[Members of the Public will be invited to provide testimony before or during consideration of each item. Makers of public comments are asked to limit their testimony to three (3) minutes.]

CLOSED SESSION

4. Discussion of Personnel [Evaluation of President] (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d) (3) (D)).

Public report of any action taken, if necessary, during closed session.

REPORTS

5. Chairman’s Report.

6. President’s Report.


ACTION ITEMS

7. Consideration of minutes from past Board meetings.
APRIL 2010 ICOC MINUTES
JUNE 2010 ICOC MINUTES

8 Consideration of implementation of reduction to Facilities Cost Part (b) Reimbursement for CIRM Major Facilities Grantees.
MEMO REGARDING FACILITIES PART B REIMBURSEMENT REDUCTION

9. Consideration of proposed new scientific members for Grants Working Group.

10. Consideration of concept proposal for Disease Teams II RFA.

11. Referral from Science Subcommittee: Consideration of staff proposal regarding policy for use of unused Disease Research Team Award funds for Clinical Trials.

12. Referral from Science Subcommittee: Consideration of proposal commissioning IOM report on CIRM.

13. Referral from Governance Subcommittee: Consideration of amendments to Contracts Policy.

14. Referral from Governance Subcommittee: Consideration of amendments to ICOC Bylaws.
MEMO REGARDING AMENDMENTS TO ICOC BYLAWS

15. Consideration of process and procedures for election of ICOC Chair and Vice-Chair.

16. Consideration of appointment of Chair and Vice-Chair of Evaluation Subcommittee.

DISCUSSION ITEMS

17. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov .

© 2013 California Institute for Regenerative Medicine